| Item Type | Name |
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Antineoplastic Agents, Hormonal
|
|
Concept
|
Antineoplastic Agents, Phytogenic
|
|
Academic Article
|
Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.
|
|
Academic Article
|
An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.
|
|
Academic Article
|
Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.
|
|
Academic Article
|
Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839.
|
|
Academic Article
|
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.
|
|
Academic Article
|
Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.
|
|
Academic Article
|
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.
|
|
Academic Article
|
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression.
|
|
Academic Article
|
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
|
|
Academic Article
|
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy.
|
|
Academic Article
|
Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?
|
|
Academic Article
|
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
|
|
Academic Article
|
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
|
|
Academic Article
|
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration.
|
|
Academic Article
|
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
|
|
Academic Article
|
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.
|
|
Academic Article
|
Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
|
|
Academic Article
|
Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.
|
|
Academic Article
|
Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
|
|
Academic Article
|
[A phase I study of combination-therapy with gemcitabine and epitope peptides derived from human vascular endothelial growth factor receptor for unresectable or recurrent pancreas cancer].
|
|
Academic Article
|
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
|
|
Academic Article
|
Genome-wide screening by cDNA microarray of genes associated with matrix mineralization by human mesenchymal stem cells in vitro.
|
|
Academic Article
|
Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis.
|
|
Academic Article
|
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.
|
|
Academic Article
|
Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
|
|
Academic Article
|
The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
|
|
Academic Article
|
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).
|
|
Academic Article
|
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
|
|
Academic Article
|
[SNP collection, pharmacogenomics, and the future of drug therapy].
|
|
Academic Article
|
Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis.
|
|
Academic Article
|
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
|
|
Academic Article
|
Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
|
|
Academic Article
|
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.
|
|
Academic Article
|
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
|
|
Academic Article
|
A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.
|
|
Academic Article
|
[S-1/CDDP combined neoadjuvant chemotherapy and surgical resection for advanced gastric cancer. Analysis of 12 patients with lymph node metastasis in Saitama Red Cross Hospital].
|
|
Academic Article
|
Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines.
|
|
Academic Article
|
Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.
|
|
Academic Article
|
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.
|
|
Academic Article
|
Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target.
|
|
Academic Article
|
VAV3 mediates resistance to breast cancer endocrine therapy.
|
|
Academic Article
|
Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation.
|
|
Academic Article
|
Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.
|
|
Academic Article
|
Molecular target therapy for synovial sarcoma.
|
|
Academic Article
|
TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis.
|
|
Academic Article
|
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.
|
|
Academic Article
|
The NSD family of protein methyltransferases in human cancer.
|
|
Academic Article
|
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
|
|
Academic Article
|
Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
|
|
Academic Article
|
Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies.
|
|
Academic Article
|
From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma.
|
|
Academic Article
|
Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy.
|
|
Academic Article
|
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
|
|
Academic Article
|
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
|
|
Academic Article
|
Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells.
|
|
Academic Article
|
Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study.
|
|
Academic Article
|
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
|
|
Academic Article
|
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
|
|
Academic Article
|
The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
|
|
Academic Article
|
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors.
|
|
Academic Article
|
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
|
|
Academic Article
|
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.
|
|
Academic Article
|
Functional genomics for breast cancer drug target discovery.
|
|
Concept
|
Antineoplastic Agents, Immunological
|